“Evaluation of Paclitaxel As a Non-Cross-Resistant Agent in Cisplatin-Resistant Small Cell Lung Cancer (SCLC)”. International Cancer Research Journal, vol. 1, no. 1, Sept. 2025, p. 2, https://doi.org/10.70844/icrj.2025.1.2.